Last Posted: May 26, 2022
- Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use.
Proudman David et al. Journal of medical economics 2022 1-25 - The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence.
Hayeems Robin Z et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021 12 (3) 694-702 - Effect of an artificial intelligence-assisted tool on non-valvular atrial fibrillation anticoagulation management in primary care: protocol for a cluster randomized controlled trial.
Ru Xueying et al. Trials 2022 23(1) 316 - Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
Xiao Gefei et al. PloS one 2022 17(4) e0266718 - Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower cost.
Riku Shan et al. Journal of medical economics 2022 1-29 - Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer.
Vanderpoel Julie et al. Journal of medical economics 2022 1-17 - Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
Burke Tom et al. Journal of medical economics 2022 1-21 - Genetic-Guided Pharmacotherapy for Atrial Fibrillation: A Systematic and Critical Review of Economic Evaluations.
Kamil Ahmad Amir et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2022 25(3) 461-472 - Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities.
Hendrix Nathaniel et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2022 25(3) 331-339 - Do People Favor Artificial Intelligence Over Physicians? A Survey Among the General Population and Their View on Artificial Intelligence in Medicine.
Yakar Derya et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2022 25(3) 374-381
More
Search Result Summary
- CDC Information (0)
- NIH Information (0)
- CDC Publications (1)
- COVID-19 (59)
- Human Genome Epidemiologic Studies (39)
- GWAS Studies (1)
- Human Genomics Translation/Implementation Studies (45)
- Genomic Tests Evidence Synthesis (50)
- Genomic Tests Guidelines (1)
- Tier-Classified Guidelines (1)
- Non-Genomics Precision Health (22)
- Pathogen Advanced Molecular Detection (0)
- State Public Health Genomics Programs (0)
- Ethical/Legal and Social Issues (ELSI) (15)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:May 28, 2022
- Content source: